Matching Items (2)
Filtering by

Clear all filters

147901-Thumbnail Image.png
Description

When discussing gay literature in the French, contemporary sphere, one of the most up
and coming and prominent authors is Édouard Louis. His works’ focus on the realism and
violence of the working class offers a critical and necessary perspective of the gay experience in
modern-day France. While recent in their creation, Louis’

When discussing gay literature in the French, contemporary sphere, one of the most up
and coming and prominent authors is Édouard Louis. His works’ focus on the realism and
violence of the working class offers a critical and necessary perspective of the gay experience in
modern-day France. While recent in their creation, Louis’ works follow a connecting thread that
is inseparable from other autofiction novels that have a narrator with same sex attractions such as
Annie Ernaux’s Ce qu’ils disent or rien and Didier Eribon’s Retour à Reims. Often commonly
discussed as French LGBT literature, these autofictional works that extend from Gide to Eribon
to now Louis demonstrate how the proposed societal dualities, limitations, and hierarchies
described by philosophers like Michel Foucault and Judith Butler affect homosexual
performativity. Louis’ first novel En finir avec Eddy Bellegueule, published on January 2, 2014,
offers another illustration of this analysis. It specifically describes the metaphysical
(metaphysical being the relationship between the outer stimuli and internal perspective) effects
and constraints of current poverty on homosexual performativity. By analyzing En finir avec
Eddy Bellegueule through this theoretical framework of power and poverty, this thesis adds a
theoretical and intersectional nuance to the narrative voice that current literature focusing on the
novel’s landscape mentions but does not reflect on. I argue that it is important to attach an
autofictional timeline that is necessary to promote and apply future ontological doctrines to this
genre.

ContributorsYanez, Mariano (Author) / Canovas, Frédéric (Thesis director) / Agruss, David (Committee member) / School of International Letters and Cultures (Contributor, Contributor, Contributor, Contributor) / Dean, The College of Liberal Arts and Sciences (Contributor) / Barrett, The Honors College (Contributor)
Created2021-05
132773-Thumbnail Image.png
Description
Heart disease is the number one killer of men and women in the world. The incidence of cardiovascular disease is known to be much higher in men than women until around the ages of 60-75 years, when the occurrence of the disease becomes approximately equal in both sexes. Additionally, the

Heart disease is the number one killer of men and women in the world. The incidence of cardiovascular disease is known to be much higher in men than women until around the ages of 60-75 years, when the occurrence of the disease becomes approximately equal in both sexes. Additionally, the occurrence of heart disease is significantly lower in premenopausal women than postmenopausal women. Since men have a higher risk for heart disease than women until 10-15 years after the average age of menopause and postmenopausal women have a higher risk of cardiovascular disease than premenopausal women, it is hypothesized that endogenous estrogen exposure throughout the fertile period of a woman's life postpones the onset of cardiovascular disease. Research shows estrogen has beneficial effects on the cardiovascular system by regulating multiple metabolic processes including lipid metabolism, vasodilation, nitric oxide synthesis, cytochrome c apoptosis, and mitochondrial antioxidant production. Though estrogen has been found to have cardiovascular benefits on individual metabolic processes, the treatment of synthetic estrogen on postmenopausal women and men to reduce the overall risk of heart disease is very controversial. The controversy of synthetic estrogen is partially due to the fact that most studies done using estrogen replacement therapy on postmenopausal women and men resulted in either no effects or harmful effects on the cardiovascular system. Hormone replacement therapy has also been associated with a higher risk of multiple medical conditions, especially venous thromboembolism and breast cancer. This review will explore these topics and consider the costs and benefits of estrogen replacement therapy.
ContributorsWeng, Tina Savanna (Author) / Hyatt, J.P. (Thesis director) / Kingsbury, Jeffrey (Committee member) / Dean, The College of Liberal Arts and Sciences (Contributor) / School of Life Sciences (Contributor) / Dean, W.P. Carey School of Business (Contributor) / Barrett, The Honors College (Contributor)
Created2019-05